BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 12149192)

  • 1. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo.
    McQuibban GA; Gong JH; Wong JP; Wallace JL; Clark-Lewis I; Overall CM
    Blood; 2002 Aug; 100(4):1160-7. PubMed ID: 12149192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3.
    McQuibban GA; Gong JH; Tam EM; McCulloch CA; Clark-Lewis I; Overall CM
    Science; 2000 Aug; 289(5482):1202-6. PubMed ID: 10947989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx.
    Dean RA; Cox JH; Bellac CL; Doucet A; Starr AE; Overall CM
    Blood; 2008 Oct; 112(8):3455-64. PubMed ID: 18660381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte chemoattractant protein-2 can exert its effects through the MCP-1 receptor (CC CKR2B).
    Yamagami S; Tanaka H; Endo N
    FEBS Lett; 1997 Jan; 400(3):329-32. PubMed ID: 9009224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact.
    Van den Steen PE; Proost P; Wuyts A; Van Damme J; Opdenakker G
    Blood; 2000 Oct; 96(8):2673-81. PubMed ID: 11023497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor.
    Proost P; Struyf S; Couvreur M; Lenaerts JP; Conings R; Menten P; Verhaert P; Wuyts A; Van Damme J
    J Immunol; 1998 Apr; 160(8):4034-41. PubMed ID: 9558113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
    Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P
    J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1.
    McQuibban GA; Butler GS; Gong JH; Bendall L; Power C; Clark-Lewis I; Overall CM
    J Biol Chem; 2001 Nov; 276(47):43503-8. PubMed ID: 11571304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.
    Knäuper V; Will H; López-Otin C; Smith B; Atkinson SJ; Stanton H; Hembry RM; Murphy G
    J Biol Chem; 1996 Jul; 271(29):17124-31. PubMed ID: 8663255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B.
    Combadiere C; Ahuja SK; Van Damme J; Tiffany HL; Gao JL; Murphy PM
    J Biol Chem; 1995 Dec; 270(50):29671-5. PubMed ID: 8530354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3.
    Bonini JA; Martin SK; Dralyuk F; Roe MW; Philipson LH; Steiner DF
    DNA Cell Biol; 1997 Oct; 16(10):1249-56. PubMed ID: 9364936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities.
    Van Den Steen PE; Wuyts A; Husson SJ; Proost P; Van Damme J; Opdenakker G
    Eur J Biochem; 2003 Sep; 270(18):3739-49. PubMed ID: 12950257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte chemotactic protein-4: tissue-specific expression and signaling through CC chemokine receptor-2.
    Godiska R; Chantry D; Raport CJ; Schweickart VL; Trong HL; Gray PW
    J Leukoc Biol; 1997 Mar; 61(3):353-60. PubMed ID: 9060459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct expression of gelatinase A [matrix metalloproteinase (MMP)-2], collagenase-3 (MMP-13), membrane type MMP 1 (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological signals during formation and regression of the rat corpus luteum.
    Liu K; Olofsson JI; Wahlberg P; Ny T
    Endocrinology; 1999 Nov; 140(11):5330-8. PubMed ID: 10537164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
    Lauer-Fields JL; Broder T; Sritharan T; Chung L; Nagase H; Fields GB
    Biochemistry; 2001 May; 40(19):5795-803. PubMed ID: 11341845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines.
    Opdenakker G; Froyen G; Fiten P; Proost P; Van Damme J
    Biochem Biophys Res Commun; 1993 Mar; 191(2):535-42. PubMed ID: 8461011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan.
    Büttner FH; Hughes CE; Margerie D; Lichte A; Tschesche H; Caterson B; Bartnik E
    Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):159-65. PubMed ID: 9639575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte chemoattractant protein-3, but not monocyte chemoattractant protein-2, is a functional ligand of the human monocyte chemoattractant protein-1 receptor.
    Franci C; Wong LM; Van Damme J; Proost P; Charo IF
    J Immunol; 1995 Jun; 154(12):6511-7. PubMed ID: 7759884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding.
    Galant C; Berlière M; Dubois D; Verougstraete JC; Charles A; Lemoine P; Kokorine I; Eeckhout Y; Courtoy PJ; Marbaix E
    Am J Pathol; 2004 Jul; 165(1):83-94. PubMed ID: 15215164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RANTES and MCP-3 antagonists bind multiple chemokine receptors.
    Gong JH; Uguccioni M; Dewald B; Baggiolini M; Clark-Lewis I
    J Biol Chem; 1996 May; 271(18):10521-7. PubMed ID: 8631850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.